A Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase
2011

A Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase

publication 10 minutes Evidence: high

Author Information

Author(s): Peter M. Schmidt, Rebecca M. Attwood, Peter G. Mohr, Susan A. Barrett, Jennifer L. McKimm-Breschkin

Primary Institution: CSIRO, Parkville, Victoria, Australia

Hypothesis

The study aims to develop a generic expression system for producing stable and soluble influenza neuraminidase.

Conclusion

The developed expression system can produce high yields of stable and soluble neuraminidase suitable for various applications.

Supporting Evidence

  • The expression system can produce milligram amounts of recombinant neuraminidase.
  • Recombinant neuraminidase showed biochemical properties closer to the original viral enzyme.
  • The Tetrabrachion stalk provided higher stability compared to the GCN4 stalk.
  • Both constructs 2 and 4 retained activity in insect cell media for weeks.
  • Milligram amounts of construct 4 NA per litre of insect cell culture were obtained.

Takeaway

Scientists created a new way to make a key protein from the flu virus that can help in making vaccines and medicines.

Methodology

The study used a baculovirus expression vector system to produce recombinant neuraminidase with different artificial stalks for stability.

Limitations

The study does not address the long-term stability of the expressed proteins under various conditions.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016284

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication